cetylpyridinium chloride + lidocaine hydrochloride monohydrate: clinical use

Prescribing considerations

• Reserve for cases where non-pharmacological measures have not provided sufficient relief.
• Confirm age-appropriateness and no use of another lidocaine-containing preparation.
• Consider relevant excipients, including ethanol, sorbitol, xylitol, benzyl alcohol, benzoic acid and chamomile-containing flavouring.
• Advise reassessment if symptoms deteriorate or appear inconsistent with uncomplicated teething.

Contraindications and cautions

• Hypersensitivity to lidocaine, cetylpyridinium chloride or any excipient.
• Use below the selected product's licensed minimum age.

Monitoring

• Clinical response and continued need.
• Application-site redness, dermatitis or hypersensitivity.
• Features suggesting illness rather than teething, including significant fever, diarrhoea, lethargy or general deterioration.
• Possible systemic toxicity after substantial accidental ingestion or excessive use.

Clinical pharmacology

Lidocaine is an amide local anaesthetic that reversibly inhibits sensory nerve-impulse generation and transmission. Cetylpyridinium chloride is a locally acting quaternary ammonium antiseptic; product pharmacokinetic data are not stated in the selected SmPC.

Formulation and product differences

• The selected product is a topical gum gel for childhood teething, not a general-purpose adult oral-pain preparation.
• It contains clinically relevant excipients including ethanol, polyols, benzoic acid, benzyl alcohol and chamomile-containing flavouring.
• Products with similar active ingredients may have different indications, age restrictions, excipients and instructions and are not interchangeable without checking product information.